Up-to-date news about Intravacc

Stay informed about the latest developments in our mission to pioneer transformative vaccines with up-to-date corporate communications. Get the latest news on our development and business milestones, as well as industry insights, partnership announcements, and corporate reports.

ShigelloisCategory icon

Intravacc announces the publication of a GMP process for a semi-synthetic Shigella glycoconjugate vaccine candidate from the Institut Pasteur

Category icon

Leiden University Medical Center and Intravacc to start clinical trial with new intranasal corona vaccine

press 1Category icon
Press releases

Intravacc’s inactivated polio vaccine, out licensed to Sinovac, receives market authorization in China

press 8Category icon
Press releases

Dutch Intravacc starts concept design for multifunctional, high-capacity vaccine plant for national requirement


press 1Category icon
Press releases

Intravacc neemt moderne pilot productiefaciliteit in gebruik en start concept-design van multifunctionele vaccinfabriek



Contact us

You can send us an email:

Reach out to Business Development:

Or pick up the phone: 
+31 30 792 03 00

You can also just fill out the contact form on the right.

We look forward to hearing from you!


Contact form

Subscribe to our newsletter